Pricing:

Single User Licence
$4200
Multi User License Upto 5 Users
$6500
Enterprise License
$8400
Download Sample Add to Cart Buy Now

Don’t see what you are Looking For:

We can create a custom report for you, please fill the form below

Download Free Sample Now

Global Pharmacovigilance Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Clinical Trial Phase;

Preclinical, Phase I, Phase II, Phase III and Phase IV.

Segmented by Service Provider;

In-house and Contract resourcing.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).

Report ID: Rn103731813 Published Date: April, 2024 Updated Date: May, 2024

Download Free Sample Now Request Customized Sample

Introduction

Global Pharmacovigilance Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

#	Global Market (USD Million), 2020 - 2030
2020	61.7
2021	67.1
2022	68.1
2023	81.5
2024	90.1
2025	90.7
2026	104.0
2027	110.2
2028	117.9
2029	139.4
2030	155.7

In the year 2023, the Global Pharmacovigilance Market was valued at USD 8,110.93 million. The size of this market is expected to increase to USD 17,299.39 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 11.4%.

Global Pharmacovigilance Market Report Snapshot

Parameters	Description
Market	Global Pharmacovigilance Market
Study Period	2020 - 2030
Base Year (for Pharmacovigilance Market Size Estimates)	2023
Study Scope	Revenue Analysis (Historical & Forecast) for all segments and geography Market Share Analysis Drivers, Restraints and Opportunity Analysis Market Opportunity Map PEST Analysis Porter's Five Forces Analysis Company's SWOT Analysis Competitors Product Heat Map Analysis
Market Segmentation	Clinical Trial Phase (Preclinical, Phase I, Phase II, Phase III and Phase IV.) Service Provider (In-house and Contract resourcing.)
Geographical Coverage	North America Europe Asia Pacific Middle East and Africa Latin America
Company Coverage	Accenture Boehringer Ingelheim Bristol-Myers Squibb Clinquest Group B.V. Cognizant Technology Solutions Corporation Ecron Acunova Ltd F. Hoffmann-La Roche Ltd GlaxoSmithKline HCL Technologies IBM Corporation ICON plc iGATE Corporation (Capgemini) Infosys Ltd InVentiv Health Clinical Ipca Laboratories Ltd IQVIA (QuintilesIMS) ITclinical Janssen Research & Development, LLC Laboratory Corporation of America Holdings Novartis AG Oracle Corporation PAREXEL International Corporation Pfizer Sanofi Aventis TCS Wipro
Premium Insights	Latest Updates Analyst Views Future Outlook of the Market

Market Analysis

This report extensively covers different segments of Global Pharmacovigilance Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points, pharmacovigilance market in india, Pharmacovigilance trends, Pharmacovigilance outsourcing, Deloitte pharmacovigilance, Salary growth in pharmacovigilance, Linical accelovance and, insights that are generated from analysis of these data points (data trends and patterns).

Global Pharmacovigilance Market Analysis

In this report, the Global Pharmacovigilance Market has been segmented by Clinical Trial Phase, Service Provider and Geography.

Global Pharmacovigilance Market, Segmentation by Clinical Trial Phase

The Global Pharmacovigilance Market has been segmented by Clinical Trial Phase into Preclinical, Phase I, Phase II, Phase III and Phase IV. The complete Global Pharmacovigilance Market segmentation by Clinical Trial Phase can be seen below:

Global Pharmacovigilance Market, By Clinical Trial Phase
- Preclinical
- Phase I
- Phase II
- Phase III
- Phase IV

This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Clinical Trial Phases mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.

The report also provides an analysis of why the market size of the various segments by Clinical Trial Phase is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.

Global Pharmacovigilance Market, by Clinical Trial Phase (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

#	Preclinical	Phase I	Phase II	Phase III	Phase IV
2020	90.5	71.5	78.4	80.4	94.8
2021	105.0	81.8	91.5	84.3	110.3
2022	110.1	88.3	92.4	89.7	111.5
2023	124.2	103.7	94.5	95.2	113.3
2024	140.7	121.0	96.7	102.3	125.3
2025	165.2	125.7	114.7	112.7	148.3
2026	168.9	147.9	119.4	132.4	155.7
2027	201.9	173.4	130.4	145.7	181.2
2028	218.5	200.8	134.6	158.9	198.1
2029	251.4	229.8	144.7	171.3	217.5
2030	285.3	245.9	159.0	191.6	240.1

Global Pharmacovigilance Market, Segmentation by Service Provider

The Global Pharmacovigilance Market has been segmented by Service Provider into In-house and Contract resourcing. The complete Global Pharmacovigilance Market segmentation by Service Provider can be seen below:

Global Pharmacovigilance Market, By Service Provider
- In-house
- Contract resourcing

This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Service Providers mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.

The report also provides an analysis of why the market size of the various segments by Service Provider is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.

Global Pharmacovigilance Market, by Service Provider (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

#	In-house	Contract resourcing
2020	65.8	67.1
2021	72.3	70.2
2022	82.8	73.6
2023	89.7	84.1
2024	100.2	94.9
2025	104.3	112.3
2026	105.2	116.9
2027	116.2	132.7
2028	126.0	147.0
2029	132.1	160.8
2030	149.2	191.5

Global Pharmacovigilance Market, Segmentation by Geography

In this report, the Global Pharmacovigilance Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Pharmacovigilance Market Share (%), by Geographical Region, 2023

North America	Europe	Asia Pacific	Middle East & Africa	Latin America
20	10	15	5	50

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Find below the list of Countries covered in each of the aforementioned geographical regions:

North America - United States, Canada and Mexico

Latin America - Brazil, Argentina and Rest of Latin America

Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe

Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific

Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa

This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Pharmacovigilance Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.

This report also provides an analysis of why the market size of Pharmacovigilance in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.

Market Dynamics

This report provides an in depth analysis of various factors that impact the dynamics of Global Pharmacovigilance Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.

Drivers, Restraints and Opportunity Analysis

The growth of the Global Pharmacovigilance Market is driven by; Growth in adoption rate of outsourcing services in Asia Pacific, Increasing consumption of drugs in developed regions, Rise in adverse drug reactions (ADR) and drug toxicity, Increasing acceptance of personalized medicine in developed regions and Effective global harmonization practices.
The factors hindering the growth of Global Pharmacovigilance Market will be discussed in detail in the full report.
The new opportunities in Global Pharmacovigilance Market will be discussed in detail in the full report.

Drivers

Growth in adoption rate of outsourcing services in Asia Pacific.
Increasing consumption of drugs in developed regions.
Rise in adverse drug reactions (ADR) and drug toxicity.
Increasing acceptance of personalized medicine in developed regions.
Effective global harmonization practices.

Restraints

Global Pharmacovigilance Market Restraints will be discussed in detail in the full report.

Opportunities

Global Pharmacovigilance Market Opportunities will be discussed in detail in the full report.

Market Opportunity Map

This report provides market opportunity map for Pharmacovigilance Market. The opportunity map (by market segments; Clinical Trial Phase and Service Provider) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.

Global Pharmacovigilance Market, Opportunity Map, By Region (2020 - 2030)

Middle East and Africa

Europe

Asia Pacific

Latin America

North America

North America	Europe	Asia Pacific	Middle East & Africa	Latin America
20	10	15	5	50

*Graph shown for illustrative purpose only, the final report will have the bubble Graphs for all the market segments along with the regions

PEST (Political, Economic, Social and Technological) Analysis

This report provides PEST analysis of Pharmacovigilance Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.

This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.

This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market

As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.

Political

In depth analysis and insights about the impact of political factors on this market will be provided in the final report.

Economic

In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.

Social

In depth analysis and insights about the impact of social factors on this market will be provided in the final report.

Technological

In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.

*PEST Analysis representation shown for illustrative purpose only, the final report will have the full PEST Analysis.

Porter's Five Force Analysis

This report provides Porter's Five Forces analysis of Global Pharmacovigilance Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.

Bargaining Power of Suppliers:

Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Pharmacovigilance Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.

Bargaining Power of Suppliers

Supplier Switching Costs Relative To Firm Switching Costs	Strength of Distribution Channels	Supplier Concentration to firm Concentration Ratio	Presence of Substitute Inputs	Supplier Competition and Possibly of Forward Integration
20	10	15	5	50

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Bargaining Power of Buyers:

Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Pharmacovigilance Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.

Bargaining Power of Buyers

Buyer Competition to Firm Concentration Ratio	Buyer Switching Costs	Availability of existing Substitute Products	Buyer Price Sensitivity	Degree of Dependency upon Existing Channels of Distribution
10	15	25	45	32

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Threat of Substitutes:

Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Pharmacovigilance Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.

Threat of Substitutes:

Availability of Substitutes	Number of Available Substitutes	Price of Substitute Products	Buyer Switching Costs	Buyer Propensity to Substitute
20	35	10	2	5

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Threat of New Entrants:

Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Pharmacovigilance Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.

Threat of New Entrants:

Barriers to entry	Economics of scale	Product Differentiation	Customer Loyalty	Network Effect	Access to Ditribution Channels
2	35	25	10	15	55

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Competitive Rivalry:

Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Pharmacovigilance Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.

Industry Rivalry:

Firm Concentration Ratio	Level of Advertising Expense	Sustainable Competitive Adavantage through Innovation	Degree of Transparency	Competitive strategy
5	10	15	35	45

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Competitive Landscape Analysis

Key players in Global Pharmacovigilance Market include, Accenture, Boehringer Ingelheim, Bristol-Myers Squibb, Clinquest Group B.V., Cognizant Technology Solutions Corporation, Ecron Acunova Ltd, F. Hoffmann-La Roche Ltd, GlaxoSmithKline, HCL Technologies, IBM Corporation, ICON plc, iGATE Corporation (Capgemini), Infosys Ltd, InVentiv Health Clinical, Ipca Laboratories Ltd, IQVIA (QuintilesIMS), ITclinical, Janssen Research & Development, LLC, Laboratory Corporation of America Holdings, Novartis AG, Oracle Corporation, PAREXEL International Corporation, Pfizer, Sanofi Aventis, TCS and Wipro.

In this report, the profile of each market player provides following information:

Company Overview and Product Portfolio
Key Developments
Financial Overview
Strategies
Company SWOT Analysis

Company SWOT Analysis

*SWOT Analysis representation shown for illustrative purpose only, the final report will have the full SWOT Analysis for every player

This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.

Competitors Products/Services Heat Map Analysis

Company Vs. Product/Service	Company 1	Company 2	Company 3	Company 4	Company 5	Company 6	Company 7	Company 8	Company 9	Company 10
Product 1/Service 1
Product 2/Service 2
Product 3/Service 3
Product 4/Service 4
Product 5/Service 5
Product 6/Service 6
Product 7/Service 7
Product 8/Service 8

Presence Absence

*Heat Map shown for illustrative purpose only, the final report will have the full Heat Map Analysis

Introduction
1. Research Objectives and Assumptions
2. Research Methodology
3. Abbreviations
Market Definition & Study Scope
Executive Summary
1. Market Snapshot, By Clinical Trial Phase
2. Market Snapshot, By Service Provider
3. Market Snapshot, By Region
4. Market Opportunity Map
Global Pharmacovigilance Market Dynamics
1. Drivers, Restraints and Opportunities
  1. Drivers
    1. Growth in adoption rate of outsourcing services in Asia Pacific
    2. Increasing consumption of drugs in developed regions
    3. Rise in adverse drug reactions (ADR) and drug toxicity
    4. Increasing acceptance of personalized medicine in developed regions
    5. Effective global harmonization practices
  2. Restraints
  3. Opportunities
2. Regulatory Scenario
3. Reimbursement Scenario
4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
5. Pipeline Analysis/Technological Advancements
6. PEST Analysis
  1. Political Analysis
  2. Economic Analysis
  3. Social Analysis
  4. Technological Analysis
7. Porter's Analysis
  1. Bargaining Power of Suppliers
  2. Bragaining Power of Buyers
  3. Threat of Substitutes
  4. Threat of New Entrants
  5. Industry Rivalry
Market Segmentation
1. Global Pharmacovigilance Market, By Clinical Trial Phase, 2022 - 2032 (USD Million)
  1. Introduction
  2. Market Share Analysis, 2024 and 2030 (%)
  3. Y-o-Y Growth Analysis, 2021 - 2030
  4. Segment Trends
    1. Preclinical
      1. Introduction
      2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Phase I
      1. Introduction
      2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Phase II
      1. Introduction
      2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    4. Phase III
      1. Introduction
      2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    5. Phase IV
      1. Introduction
      2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
2. Global Pharmacovigilance Market, By Service Provider, 2022 - 2032 (USD Million)
  1. Introduction
  2. Market Share Analysis, 2024 and 2030 (%)
  3. Y-o-Y Growth Analysis, 2021 - 2030
  4. Segment Trends
    1. In-house
      1. Introduction
      2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Contract resourcing
      1. Introduction
      2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
3. Global Pharmacovigilance Market, By Geography, 2022 - 2032 (USD Million)
  1. Introduction
  2. Market Share Analysis, 2024 and 2030 (%)
  3. Y-o-Y Growth Analysis, 2021 - 2030
  4. Regional Trends
    1. North America
      1. Introduction
      2. Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
      3. Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        United States
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        Canada
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
    2. Europe
      1. Introduction
      2. Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
      3. Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        Germany
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        United Kingdom
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        France
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        Italy
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        Spain
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        Rest of Europe
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
    3. Asia Pacific
      1. Introduction
      2. Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
      3. Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        Japan
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        China
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        India
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        Australia & New Zealand
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        South Korea
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        ASEAN (Association of South East Asian Countries)
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        Rest of Asia Pacific
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
    4. Latin America
      1. Introduction
      2. Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
      3. Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        Brazil
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        Mexico
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        Argentina
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        Rest of Latin America
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
    5. Middle East & Africa
      1. Introduction
      2. Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
      3. Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        GCC
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        Israel
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        South Africa
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
        
        Rest of Middle East & Africa
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2020 - 2030 (USD Million)
        
        Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020 - 2030 (USD Million)
Competitive Landscape
1. Heat Map Analysis
2. Company Profiles
  1. Accenture
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  2. Boehringer Ingelheim
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  3. Bristol-Myers Squibb
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  4. Clinquest Group B.V.
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  5. Cognizant Technology Solutions Corporation
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  6. Ecron Acunova Ltd
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  7. F. Hoffmann-La Roche Ltd
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  8. GlaxoSmithKline
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  9. HCL Technologies
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  10. IBM Corporation
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  11. ICON plc
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  12. iGATE Corporation (Capgemini)
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  13. Infosys Ltd
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  14. InVentiv Health Clinical
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  15. Ipca Laboratories Ltd
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  16. IQVIA (QuintilesIMS)
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  17. ITclinical
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  18. Janssen Research & Development, LLC
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  19. Laboratory Corporation of America Holdings
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  20. Novartis AG
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  21. Oracle Corporation
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  22. PAREXEL International Corporation
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  23. Pfizer
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  24. Sanofi Aventis
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  25. TCS
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
  26. Wipro
    1. Company Overview and Product Portfolio
    2. Key Developments
    3. Financial Overview
    4. Strategies
    5. Company SWOT Analysis
Analyst Views
Future Outlook of the Market

Download Free Sample Now Request Customized Sample

ReAnIn's Most Viewed Titles:

Healthcare Latest In Healthcare Pharmerging Contract Manufacturing

Global Pharmerging Contract Manufacturing Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Pharmerging Contract Manufacturing Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...

Healthcare In Vitro Diagnostics Phenytoin Testing

Global Phenytoin Testing Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Phenytoin Testing Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...

Healthcare Medical Devices Pharmacy And Reagent Storage Refrigerators

Global Pharmacy And Reagent Storage Refrigerators Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Pharmacy And Reagent Storage Refrigerators Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...

Healthcare Medical Devices Pharma-grade Synthetic Camphor

Global Pharma-grade Synthetic Camphor Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Pharma-grade Synthetic Camphor Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...

S.No	Report Title	Type of Currency	Price
1	Title		$49/user
2	Title		$49/user
		Total	$200
Total Price :

Pricing:

Custom Report Request Form

Global Pharmacovigilance Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Clinical Trial Phase;

Segmented by Service Provider;

Segmented by Geography;

Introduction

Global Pharmacovigilance Market (USD Million), 2020 - 2030

Global Pharmacovigilance Market Report Snapshot

Market Analysis

Global Pharmacovigilance Market Analysis

Global Pharmacovigilance Market, Segmentation by Clinical Trial Phase

Global Pharmacovigilance Market, by Clinical Trial Phase (USD Million), 2020 - 2030

Global Pharmacovigilance Market, Segmentation by Service Provider

Global Pharmacovigilance Market, by Service Provider (USD Million), 2020 - 2030

Global Pharmacovigilance Market, Segmentation by Geography

Global Pharmacovigilance Market Share (%), by Geographical Region, 2023

Market Dynamics

Drivers, Restraints and Opportunity Analysis

Market Opportunity Map

Global Pharmacovigilance Market, Opportunity Map, By Region (2020 - 2030)

PEST (Political, Economic, Social and Technological) Analysis

Porter's Five Force Analysis

Bargaining Power of Suppliers:

Bargaining Power of Suppliers

Bargaining Power of Buyers:

Bargaining Power of Buyers

Threat of Substitutes:

Threat of Substitutes:

Threat of New Entrants:

Threat of New Entrants:

Competitive Rivalry:

Industry Rivalry:

Competitive Landscape Analysis

Company SWOT Analysis

Competitors Products/Services Heat Map Analysis

ReAnIn's Most Viewed Titles: